Julien Adam
Impact in
- Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Oncology 100
- Cancer Immunotherapy and Biomarkers 63
- Lung Cancer Research Studies 14
-
- Lung Cancer Treatments and Mutations 32
- Sarcoma Diagnosis and Treatment 21
- Co-authors
- Benjamin Besse (35 shared papers)Vincent de Montpréville (11 shared papers)Aïcha Goubar (5 shared papers)David Planchard (32 shared papers)Jean‐Charles Soria (27 shared papers)Fathia Mami‐Chouaib (4 shared papers)Pierre Validire (4 shared papers)Axel Le Cesne (16 shared papers)
- Journals
- Annals of Oncology (33 papers)Journal of Thoracic Oncology (10 papers)OncoImmunology (8 papers)European Journal of Cancer (6 papers)Cancers (5 papers)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Julien Adam
191 papers receiving 12.4k citations
Julien Adam's Hit Papers
Peers
Comparison fields: 5 of 124
- Oncology 6.9k
- Immunology 3.5k
- Cancer Research 1.7k
- Pulmonary and Respiratory Medicine 3.1k
- Pathology and Forensic Medicine 630
Countries citing papers authored by Julien Adam
This map shows the geographic impact of Julien Adam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julien Adam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julien Adam more than expected).
Fields of papers citing papers by Julien Adam
This network shows the impact of papers produced by Julien Adam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julien Adam. The network helps show where Julien Adam may publish in the future.
Co-authors
The 25 scholars most cited alongside Julien Adam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 196 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | B cells are associated with survival and immunotherapy response in sarcoma Hit paper breakdown → | 2020 | 1466 |
| 2 | Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy Hit paper breakdown → | 2014 | 888 |
| 3 | Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non–Small Cell Lung Cancer Hit paper breakdown → | 2018 | 706 |
| 4 | Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy Hit paper breakdown → | 2018 | 580 |
| 5 | CD8+CD103+ Tumor–Infiltrating Lymphocytes Are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer Patients Hit paper breakdown → | 2015 | 510 |
| 6 | 2015 | 409 | |
| 7 | 2017 | 346 | |
| 8 | Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas Hit paper breakdown → | 2017 | 337 |
| 9 | 2013 | 314 | |
| 10 | 2017 | 274 | |
| 11 | 2018 | 274 | |
| 12 | 2013 | 247 | |
| 13 | Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumors Hit paper breakdown → | 2022 | 243 |
| 14 | 2018 | 200 | |
| 15 | 2019 | 198 | |
| 16 | 2021 | 193 | |
| 17 | 2018 | 189 | |
| 18 | 2015 | 174 | |
| 19 | 2020 | 164 | |
| 20 | 2020 | 156 |
About Julien Adam
Julien Adam is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Immunology and Pathology and Forensic Medicine, having authored 196 papers that have together received 12.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (63 papers), Lung Cancer Treatments and Mutations (32 papers), Sarcoma Diagnosis and Treatment (21 papers), Cancer Genomics and Diagnostics (20 papers), Lung Cancer Research Studies (14 papers), Immunotherapy and Immune Responses (14 papers), Immune Cell Function and Interaction (13 papers) and Lymphoma Diagnosis and Treatment (10 papers). The work is most often cited by research in Oncology (6.9k citations), Immunology (3.5k citations), Cancer Research (1.7k citations), Pulmonary and Respiratory Medicine (3.1k citations) and Pathology and Forensic Medicine (630 citations). Julien Adam has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Benjamin Besse, Vincent de Montpréville, Aïcha Goubar, David Planchard, Jean‐Charles Soria, Fathia Mami‐Chouaib, Pierre Validire, Axel Le Cesne, Aurélie Durgeau and Guillaume Meurice. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, OncoImmunology, European Journal of Cancer and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.